The EFMC - ACSMEDI Medicinal Chemistry Frontiers is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry).
The Final Scientific Programme will include:
This biennial meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. The EFMC - ACSMEDI Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for this meeting will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.
The Conference topics will cover:
Discover the Final Programme here!